Measuring Outcomes in Palliative Care: Limitations of QALYs and the Road to PalYs

Journal of Pain and Symptom Management

Volumn 38, Issue 1, 2009, Pages 27-31

  Normand, Charles ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

economic evaluation; End of life care; outcomes; palliative care; priority setting; QALYs

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; HEALTH CARE; HEALTH CARE QUALITY; OUTCOME ASSESSMENT; PALLIATIVE THERAPY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; SOCIAL CARE;

HUMANS; IRELAND; OUTCOME ASSESSMENT (HEALTH CARE); PAIN; PALLIATIVE CARE; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; SENSITIVITY AND SPECIFICITY; TERMINAL CARE;

EID: 67650151567     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2009.04.005     Document Type: Article

References (17)

1. Carr-Hill R.A. Allocating resources to health care: is the QALY (quality adjusted life year) a technical solution to a political problem?. Int J Health Serv 21 (1991) 351-363
2. Drummond M., Sculpher M., Torrance G., O'Brien B., and Stoddart G. Methods for the economic evaluation of health care programmes (2005), Oxford University Press, Oxford
3. Williams A. Is the QALY a technical solution to a political problem? Of course not!. Int J Health Serv 21 (1991) 365-369 Discussion pp. 371-372
4. Gafni A., and Birch S. Preferences for outcomes in economic evaluation: an economic approach to addressing economic problems. Soc Sci Med 40 (1995) 767-776
5. Gafni A., Birch S., and Mehrez A. Economics, health and health economics: HYEs (healthy-years equivalent) versus QALYs (quality-adjusted live-year). J Health Econ 12 (1993) 325-339
6. Culyer AJ, Wagstaff A. QALYs versus HYEs: a theoretical exposition. CHE/HEC Discussion Paper 99. York: University of York, 1992.
7. Hughes J. Palliative care and the QALY problem. Health Care Anal 13 (2005) 289-301
8. Douglas H.R., Normand C., Higginson I., and Goodwin D. New approach to eliciting patients' preferences for palliative day care: the choice experiment method. J Pain Symptom Manage 29 (2005) 435-445
9. Bravo Vergel Y., Hawkins N.S., Claxton K., et al. The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis. Rheumatology (Oxford) 46 (2007) 1729-1735
10. Tappenden P., Chilcott J., Ward S., et al. Methodological issues in the economic analysis of cancer treatments. Eur J Cancer 17 (2006) 2867-2875 Epub October 4, 2006
11. van den Hout W.B., Kramer G.W., Noordijk E.M., and Leer J.W. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer. J Natl Cancer Inst 98 (2006) 1786-1794
12. Sculpher M.J., Pang F.S., Manca A., et al. Generalisability in economic evaluation studies in healthcare: a review and case studies. Health Technol Assess 8 iii-iv (2004) 1-192
13. Moatti J.P., Auquier P., Le Coroller A.G., and Macquart-Moulin G. QALYS or not QALYS: that is the question?. Rev Epidemiol Sante Publique 43 (1995) 573-583
14. Arrow K.J. Social choice and individual values (1951), John Wiley, New York
15. Hearn J., and Higginson I.J. Development and validation of a core outcome measure for palliative care: the palliative care outcome scale. Qual Health Care 8 (1999) 219-227
16. Barnato A.E., Herndon M.B., Anthony D.L., et al. Are regional variations in end-of-life care intensity explained by patient preferences? A study of the US Medicare population. Med Care 45 (2007) 386-393
17. Higginson I.J., Hearn J., Myers K., et al. Palliative day care: what do services do?. Palliat Med 14 (1999) 277-286